Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
A hemostatic tissue sealant sponge and a spray for acute wounds are disclosed. The sponge comprises hydrophobically modified polymers that anchor themselves within the membrane of cells in the vicinity of the wound. The seal is strong enough to substantially prevent the loss of blood inside the boundaries of the sponge, yet weak enough to substantially prevent damage to newly formed tissue upon recovery and subsequent removal of the sponge. In examples, the polymers inherently prevent microbial infections and are suitable for oxygen transfer required during normal wound metabolism. The spray comprises hydrophobically modified polymers that form solid gel networks with blood cells to create a physical clotting mechanism to prevent loss of blood. In an example, the spray further comprises at least one reagent that increases the mechanical integrity of the clot. In another example, the reagent prevents microbial infection of the wound.
1. A method of using a hydrophobically modified chitosan matrix for treatment of wounds, comprising:
administering the hydrophobically modified chitosan matrix formulated as a solid state sponge that has been made from a solution having a concentration of about 1% to about 2.5% by weight relative to the total weight of the solution of the hydrophobically modified chitosan and wherein hydrophobic substitutions occur in up to 10% of available amines of the chitosan backbone, to a damaged tissue or a red blood cell, wherein the hydrophobically modified chitosan matrix is capable of adhering to the damaged tissue or red blood cell via hydrophobic interactions; wherein the hydrophobic modifications comprise hydrocarbon substituents of eight to eighteen carbon residues in length covalently attached to chitosan.
2. The method of claim 1 , wherein the solid state sponge is formulated by a process that comprises dehydration by at least one of a drying process, freezing process or a lyophilization process.
3. The method of claim 1 , wherein hydrophobic substitutions occur in between 1.5 and 4.5% of available amines of the chitosan backbone.